METABOLISM OF SCHISTOSOMES - REVIEW

被引:57
作者
COLES, GC [1 ]
机构
[1] MOLTENO INST, DOWNING ST, CAMBRIDGE CB2 3EE, ENGLAND
来源
INTERNATIONAL JOURNAL OF BIOCHEMISTRY | 1973年 / 4卷 / 22期
关键词
D O I
10.1016/0020-711X(73)90055-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:319 / 337
页数:19
相关论文
共 172 条
[11]  
Bruce J.I., 1972, International J Parasit, V2, P425, DOI 10.1016/0020-7519(72)90086-0
[12]   SCHISTOSOMA MANSONI - GLYCOGEN CONTENT AND UTILIZATION OF GLUCOSE, PYRUVATE, GLUTAMATE, AND CITRIC ACID CYCLE INTERMEDIATES BY CERCARIAE AND SCHISTOSOMULES [J].
BRUCE, JI ;
WEISS, E ;
STIREWALT, MA ;
LINCICOME, DR .
EXPERIMENTAL PARASITOLOGY, 1969, 26 (01) :29-+
[13]   PROPHYLACTIC AND CURATIVE ACTIVITY OF SODIUM ANTIMONY DIMERCAPTO SUCCINATE (TWSB) IN EXPERIMENTAL INFECTIONS WITH SCHISTOSOMA MANSONI [J].
BRUCE, JI ;
SCHOENBECHLER, MJ ;
SADUN, EH .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1962, 11 (01) :25-&
[14]   SCHISTOSOMA-MANSONI AND SCHISTOSOMA-JAPONICUM - OXYGEN UPTAKE BY MIRACIDIA [J].
BRUCE, JI ;
RUFF, MD ;
CHIU, JK ;
HOWARD, L .
EXPERIMENTAL PARASITOLOGY, 1971, 30 (01) :124-&
[15]   RELATIONSHIP BETWEEN INHIBITION OF PHOSPHOFRUCTOKINASE ACTIVITY AND THE MODE OF ACTION OF TRIVALENT ORGANIC ANTIMONIALS ON SCHISTOSOMA-MANSONI [J].
BUEDING, E ;
MANSOUR, JM .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (02) :159-165
[16]   FACTORS AFFECTING INHIBITION OF PHOSPHOFRUCTOKINASE ACTIVITY OF SCHISTOSOMA MANSONI BY TRIVALENT ORGANIC ANTIMONIALS [J].
BUEDING, E ;
FISHER, J .
BIOCHEMICAL PHARMACOLOGY, 1966, 15 (08) :1197-&
[17]   INHIBITION BY METRIFONATE AND DICHLORVOS OF CHOLINESTERASES IN SCHISTOSOMES [J].
BUEDING, E ;
ROGERS, SH ;
LIU, CL .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 46 (03) :480-&
[18]   ACETYLCHOLINESTERASE ACTIVITY OF SCHISTOSOMA-MANSONI [J].
BUEDING, E .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1952, 7 (04) :563-566
[19]   SOME BIOCHEMICAL EFFECTS OF ANTHELMINTIC DRUGS [J].
BUEDING, E .
BIOCHEMICAL PHARMACOLOGY, 1969, 18 (07) :1541-&
[20]  
BUEDING E, 1970, MOL PHARMACOL, V6, P532